(Q37243101)

19 August 2017

1 reference

title

L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature (English)

1 reference

extranodal NK/T-cell lymphoma, nasal type

19 August 2017

0 references

1 reference

1 reference

15

1 reference

19 August 2017

N Gachard

13

0 references

Arnaud Jaccard

object named as

A Jaccard

1

0 references

author name string

B Petit

2

1 reference

19 August 2017

S Girault

3

1 reference

19 August 2017

F Suarez

4

1 reference

19 August 2017

R Gressin

5

1 reference

19 August 2017

J-M Zini

6

1 reference

19 August 2017

V Coiteux

7

1 reference

19 August 2017

C Larroche

8

1 reference

19 August 2017

A Devidas

9

1 reference

19 August 2017

C Thiéblemont

10

1 reference

19 August 2017

P Gaulard

11

1 reference

19 August 2017

B Marin

12

1 reference

19 August 2017

D Bordessoule

14

1 reference

19 August 2017

publication date

13 August 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

20

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

110-116

1 reference

Progress in understanding and managing natural killer-cell malignancies

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Revised response criteria for malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Natural killer-cell malignancies: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Selective apoptosis of natural killer-cell tumours by l-asparaginase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN542

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN542

1 reference

19 August 2017

1 reference